Proteomics of bronchoalveolar lavage fluid

被引:107
作者
Wattiez, R [1 ]
Falmagne, P [1 ]
机构
[1] Univ Mons, Dept Biol Chem, B-7000 Mons, Belgium
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2005年 / 815卷 / 1-2期
关键词
proteomics; bronchoalveolar lavage fluid;
D O I
10.1016/j.jchromb.2004.10.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Lung diseases are essentially multi-factorial diseases that require a global analysis, and thus, cannot be understood through the sole analysis of individual or small numbers of genes. Proteome analysis has rapidly developed in the post-genome era and is now widely accepted as the obligated complementary technology for genetic profiling. It has been shown to be a powerful tool for the study of human diseases and for identifying novel prognostic, diagnostic and therapeutic markers. During last years, proteomic approaches applied to lung diseases are centred on the analysis of proteins in samples, such as cell cultures, biopsies and physiological fluids like serum and, especially, bronchoalveolar lavage fluid (BALF). BALF is presently the most common way of sampling the components of the epithelial lining fluid (ELF) and the most faithful reflect of the protein composition of the pulmonary airways. This review focuses on the state of the investigations of BALF proteome and its powerful contribution both to a better knowledge of the lung structure at the molecular level and to the study of lung disorders at the clinical level. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 85 条
[21]  
Griese M, 2001, ELECTROPHORESIS, V22, P165, DOI 10.1002/1522-2683(200101)22:1<165::AID-ELPS165>3.0.CO
[22]  
2-H
[23]   Correlation between protein and mRNA abundance in yeast [J].
Gygi, SP ;
Rochon, Y ;
Franza, BR ;
Aebersold, R .
MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (03) :1720-1730
[24]   Proteomic analysis of human bronchoalveolar lavage fluid: expression profiling of surfactant-associated protein A isomers derived from human pulmonary alveolar proteinosis using immunoaffinity detection [J].
He, C .
PROTEOMICS, 2003, 3 (01) :87-94
[25]   Proteomic analyses of arsenic-induced cell transformation with SELDI-TOF ProteinChip® technology [J].
He, QY ;
Yip, TT ;
Li, MY ;
Chiu, JF .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 88 (01) :1-8
[26]   Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16 [J].
Hermans, C ;
Dong, P ;
Robin, M ;
Jadoul, M ;
Bernard, A ;
Bersten, AD ;
Doyle, IR .
BIOMARKERS, 2003, 8 (06) :461-471
[27]   Serum Clara cell protein (CC16), a marker of the integrity of the air-blood barrier in sarcoidosis [J].
Hermans, C ;
Petrek, M ;
Kolek, V ;
Weynand, B ;
Pieters, T ;
Lambert, M ;
Bernard, A .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (03) :507-514
[28]   Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features [J].
Hirano, T ;
Fujioka, K ;
Franzen, B ;
Okuzawa, K ;
Uryu, K ;
Shibanuma, H ;
Numata, K ;
Konaka, C ;
Ebihara, Y ;
Takahashi, M ;
Kato, H ;
Auer, G .
BRITISH JOURNAL OF CANCER, 1997, 75 (07) :978-985
[29]   Proteomics: Current techniques and potential applications to lung disease [J].
Hirsch, J ;
Hansen, KC ;
Burlingame, AL ;
Matthay, MA .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 287 (01) :L1-L23
[30]  
Hochstrasser DF, 2002, PROTEOMICS, V2, P807, DOI 10.1002/1615-9861(200207)2:7<807::AID-PROT807>3.0.CO